Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Co (Q39903786)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Co |
scientific article |
Statements
1 reference
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Co (English)
1 reference
Kevin J Anstrom
1 reference
Laura Mauri
1 reference
David E Kandzari
1 reference
Martin B Leon
1 reference
ENDEAVOR III Investigators
1 reference
Eric L Eisenstein
1 reference
Rex Edwards
1 reference
David F Kong
1 reference
Patricia A Cowper
1 reference
1 December 2009
1 reference
1 reference
2
1 reference
12
1 reference
1199-1207
1 reference
Identifiers
1 reference
1 reference